Trial Results
October 14, 2019
The combination of ibrutinib plus rituximab was superior to standard treatment for CLL patients age 70 and younger.
February 12, 2020
The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.
June 6, 2020
This study showed that surgery followed by low-dose radiation alone led to very good outcomes, similar to surgery with standard-dose radiation, preserving patients’ throat function and potentially sparing them unnecessary side effects.